Arcutis Biotherapeutics, Inc.ARQTNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank63
3Y CAGR-8.3%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
-8.3%/yr
Annual compound
Percentile
P63
Within normal range
vs 3Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$12.08M-55.5%
2024$27.17M-8.6%
2023$29.71M+89.8%
2022$15.65M-
2021$0.00-
2020$0.00-
2019$0.00-
2018$0.00-
2017$0.00-